Skip to main content
Glama

Curo Peptide Research MCP: PepBank Studies, Peptide Lookup and Lab Reports (COAs)

Search products

search_products
Read-onlyIdempotent

Find Curo products by peptide or product name, or list all products when query is empty. Returns name, slug, dose, price in USD, stock, a lab report link and a buy link. Use get_product for every dose of one product with its lot reports. Use peptide_research for what the studies say.

Input Schema

NameRequiredDescriptionDefault
queryNoPeptide or product name, for example BPC-157. Leave empty to list all products.

Schema Changelog

Changes observed during successful MCP inspections.

  1. Changed1 schema field changed
    • addedInput schema / properties / query / description
      Added value: +"Peptide or product name, for example BPC-157. Leave empty to list all products."
  2. First observed

TDQS

A4.4/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only, idempotent, non-destructive behavior, so the safety profile is covered. The description adds useful return-shape context (name, slug, dose, price in USD, stock, lab report and buy links) that the annotations cannot convey. It doesn't mention result caps or pagination for the list-all case, which is the one remaining gap.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three compact sentences, front-loaded with what the tool returns and how to invoke it, then sibling routing. No filler or restated name/title boilerplate.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a one-parameter read tool with no output schema, the description covers return fields, matching behavior, and alternatives to a degree that is sufficient to call it correctly. Only listing limits/truncation behavior for the empty-query path is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and the single parameter's schema description already explains the name format and the empty-query behavior. The description restates the empty-query rule but adds no new syntax or matching semantics, so the baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb (find/list) and resource (Curo products) plus the exact matching key (peptide or product name). It is clearly distinguishable from get_product and peptide_research, which are named explicitly.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Gives explicit routing: use get_product for all doses of one product with lot reports, and peptide_research for study information. It also specifies the degenerate case (empty query lists all products), leaving nothing to infer.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.